Stockscreener 앱 받기
7.85
0.51%
-0.04
시간 외 거래:
7.98
0.13
+1.66%
전일 마감가:
$7.89
열려 있는:
$7.92
하루 거래량:
1.55M
Relative Volume:
0.63
시가총액:
$1.27B
수익:
$181.41M
순이익/손실:
$-59.56M
주가수익비율:
-18.69
EPS:
-0.42
순현금흐름:
$-38.83M
1주 성능:
+0.26%
1개월 성능:
+43.25%
6개월 성능:
+108.22%
1년 성능:
+210.28%
1일 변동 폭
$7.75
$7.96
1주일 범위
$7.67
$8.03
52주 변동 폭
$2.49
$8.03
Xeris Biopharma Holdings Inc Stock (XERS) Company Profile
명칭
Xeris Biopharma Holdings Inc
전화
844-445-5704
주소
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL
XERS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XERS
Xeris Biopharma Holdings Inc
|
7.85 | 1.27B | 181.41M | -59.56M | -38.83M | -0.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Xeris Biopharma Holdings Inc Stock (XERS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-12 | 재개 | H.C. Wainwright | Buy |
| 2024-11-11 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-03-28 | 개시 | Oppenheimer | Outperform |
| 2023-08-28 | 개시 | Craig Hallum | Buy |
| 2022-10-21 | 개시 | Jefferies | Buy |
| 2022-04-28 | 개시 | Craig Hallum | Buy |
| 2021-11-17 | 개시 | SVB Leerink | Outperform |
| 2021-10-29 | 개시 | H.C. Wainwright | Buy |
| 2021-04-07 | 재개 | RBC Capital Mkts | Outperform |
| 2020-02-18 | 개시 | Piper Sandler | Overweight |
| 2018-07-16 | 개시 | Jefferies | Buy |
| 2018-07-16 | 개시 | Leerink Partners | Outperform |
| 2018-07-16 | 개시 | RBC Capital Mkts | Outperform |
모두보기
Xeris Biopharma Holdings Inc 주식(XERS)의 최신 뉴스
Is Xeris Biopharma Holdings Inc. stock a top performer YTDBear Alert & AI Driven Price Predictions - خودرو بانک
Is Xeris Biopharma Holdings Inc. forming bullish engulfing patterns2025 Trading Recap & Verified Swing Trading Watchlist - خودرو بانک
Is Xeris Biopharma Holdings Inc. stock a good dividend stockJuly 2025 Levels & Weekly High Potential Stock Alerts - خودرو بانک
Candlestick signals on Xeris Biopharma Holdings Inc. stock todayPortfolio Growth Summary & Real-Time Sentiment Analysis - Newser
Is Xeris Biopharma Holdings Inc. stock risky to hold nowBreakout Watch & High Accuracy Buy Signal Tips - خودرو بانک
Layoff Watch: Is Xeris Biopharma Holdings Inc. a good stock for dollar cost averaging2025 Key Highlights & AI Powered Market Trend Analysis - خودرو بانک
Technical signs of recovery in Xeris Biopharma Holdings Inc.2025 Volatility Report & AI Powered Buy/Sell Recommendations - Newser
Xeris In Recorlev-Fueled Growth: Why I Choose To Buy (NASDAQ:XERS) - Seeking Alpha
Is Xeris Biopharma Holdings Inc. forming a breakout patternJuly 2025 Price Swings & AI Forecasted Entry and Exit Points - خودرو بانک
Institutional scanner results for Xeris Biopharma Holdings Inc.2025 Investor Takeaways & Weekly Chart Analysis and Guides - Newser
Developing predictive dashboards with Xeris Biopharma Holdings Inc. dataTrade Exit Report & Low Drawdown Momentum Trade Ideas - Newser
Technical analysis overview for Xeris Biopharma Holdings Inc. stock2025 Market Outlook & Reliable Breakout Forecasts - Newser
Using data models to predict Xeris Biopharma Holdings Inc. stock movementPortfolio Risk Summary & Safe Capital Allocation Plans - Newser
Is Xeris Biopharma Holdings Inc. stock bottoming outPortfolio Update Report & Verified Technical Trade Signals - Newser
Can a trend reversal in Xeris Biopharma Holdings Inc. lead to recoveryForecast Cut & Free Growth Oriented Trading Recommendations - Newser
Bank Watch: Can Xeris Biopharma Holdings Inc. expand its profit marginsOil Prices & High Return Trade Guides - khodrobank.com
Xeris Pharmaceuticals stock hits 52-week high at 8.02 USD - Investing.com
Xeris Pharmaceuticals stock hits 52-week high at 8.02 USD By Investing.com - Investing.com Australia
Xeris Biopharma Holdings, Inc. (XERS) Reports Record $71.5M Q2 Revenue - MSN
What’s the fair value of Xeris Biopharma Holdings Inc. stockWall Street Watch & Risk Managed Investment Entry Signals - خودرو بانک
How cyclical is Xeris Biopharma Holdings Inc.’s revenue streamMarket Activity Report & Safe Entry Momentum Stock Tips - خودرو بانک
What’s the RSI of Xeris Biopharma Holdings Inc. stock2025 Valuation Update & Scalable Portfolio Growth Ideas - خودرو بانک
Is Xeris Biopharma Holdings Inc. stock a smart retirement pickWeekly Market Report & Low Drawdown Investment Ideas - خودرو بانک
Can Xeris Biopharma Holdings Inc. expand its profit marginsJuly 2025 Decliners & Verified Entry Point Detection - خودرو بانک
Investor Mood: Can Xeris Biopharma Holdings Inc. expand its profit margins2025 Major Catalysts & Low Drawdown Trading Techniques - خودرو بانک
What is Xeris Biopharma Holdings Inc.’s book value per shareTrade Entry Report & Low Risk High Win Rate Stock Picks - خودرو بانک
Will Xeris Biopharma Holdings Inc. see short term momentumGap Up & Daily Growth Stock Tips - Newser
Is Xeris Biopharma Holdings Inc. showing signs of accumulationChart Signals & Real-Time Chart Pattern Alerts - Newser
Xeris Biopharma Holdings Inc. stock volume spike explained2025 Momentum Check & Reliable Intraday Trade Plans - Newser
Is Xeris Biopharma Holdings Inc. stock ready for a breakout2025 Major Catalysts & Fast Exit and Entry Strategy Plans - Newser
Visualizing Xeris Biopharma Holdings Inc. stock with heatmaps2025 Fundamental Recap & Capital Protection Trade Alerts - Newser
Will Xeris Biopharma Holdings Inc. Benefit From Sector Tailwinds getLinesFromResByArray error: size == 0 - thegnnews.com
How to build a dashboard for Xeris Biopharma Holdings Inc. stockBear Alert & Low Drawdown Momentum Ideas - Newser
Xeris Biopharma Holdings Inc (XERS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):